Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ari Wijetunga

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Neuro-Oncology Advances|January 7, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasisN Ari Wijetunga, Adrienne Boire, Robert J Young, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2021
Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone MetastasesNoah J Mathis, Connor J Doyle, Daniel B Rosen, et al.
Frontiers in Oncology|April 15, 2025
Urgent and emergent radiotherapy for hematologic malignancies of the central nervous system: a review of the literature and practical approachKathryn R Tringale, Brandon S Imber, Gustav Y Cederquist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal MetastasesN Ari Wijetunga, Alexander G Goglia, Nils Weinhold, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Autocrine CXCL1-CXCR2 Signaling Mediates Leptomeningeal Resistance to Radiation TherapyAhmed M Osman, Jan Remsik, Jenna Snyder, et al.
Cancer Research Communications|August 8, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic FeaturesN Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi, et al.
JCO Precision Oncology|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung CancerN Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.
Transplantation and Cellular Therapy|January 1, 2023
Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell TherapyHarper Hubbeling, Emily A Silverman, Laure Michaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2022
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal MetastasisJonathan T Yang, N Ari Wijetunga, Elena Pentsova, et al.
JAMA Oncology|September 4, 2025
Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical TrialJonathan T Yang, Divya Yerramilli, Elena Pentsova, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Neuro-Oncology Advances|January 7, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasisN Ari Wijetunga, Adrienne Boire, Robert J Young, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2021
Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone MetastasesNoah J Mathis, Connor J Doyle, Daniel B Rosen, et al.
Frontiers in Oncology|April 15, 2025
Urgent and emergent radiotherapy for hematologic malignancies of the central nervous system: a review of the literature and practical approachKathryn R Tringale, Brandon S Imber, Gustav Y Cederquist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal MetastasesN Ari Wijetunga, Alexander G Goglia, Nils Weinhold, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Autocrine CXCL1-CXCR2 Signaling Mediates Leptomeningeal Resistance to Radiation TherapyAhmed M Osman, Jan Remsik, Jenna Snyder, et al.
Cancer Research Communications|August 8, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic FeaturesN Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi, et al.
JCO Precision Oncology|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung CancerN Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.
Transplantation and Cellular Therapy|January 1, 2023
Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell TherapyHarper Hubbeling, Emily A Silverman, Laure Michaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2022
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal MetastasisJonathan T Yang, N Ari Wijetunga, Elena Pentsova, et al.
JAMA Oncology|September 4, 2025
Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical TrialJonathan T Yang, Divya Yerramilli, Elena Pentsova, et al.
Pageof 3